1/
If you’re trying to understand what $TXTM is building — read this.
No hype.
No shortcuts.
Just the full picture.
—
2/
Start here:
$TXTM is currently OTCID.
Meaning:
EDGAR filings are not required.
Now read that again before the next part.
—
3/
Because despite that…
$TXTM established:
• Voluntary EDGAR filing capability
• Broadridge admin infrastructure
• Alignment with EDGAR Next
Above standard. By choice.
—
4/
Then comes the next layer:
Deloitte IRL (Information Request List)
This is where:
Claims → get tested
Numbers → get verified
Value → gets challenged
—
5/
So what you’re seeing is not random activity.
It’s a build sequence:
Transparency → Infrastructure → Validation
That’s how serious companies prepare.
—
6/
Now add real-world drivers:
• FX tailwinds (ZAR/USD)
• Revenue & margin impact
• Strategic roadmap (RWA, APIs, tokenization)
This is multi-layered value creation
—
7/
Here’s the part most miss:
None of this guarantees immediate recognition.
But historically…
This is exactly where asymmetry lives
—
8/
This is what a pre-repricing environment looks like:
• Structure improving
• Risk reducing
• Validation in motion
• Market still catching up
—
9/
No hype needed.
No artificial urgency.
Just a simple truth:
We said we would build.
We are building.
—
10/
$TXTM
Milestone stacking.
Execution compounding.
The more WE, WE are… the more WE are.
Simunye. Ubuntu.
Position accordingly.
Join The Movement !!!
https://t.co/aYZl0k7Vuq
🚀 UNWAVERING CONFIDENCE IN $TXTM 🚀
The president and chairman of ProText continue to ONLY buy and accumulate shares—not a single share has been sold. This speaks volumes about their deep belief in ProText’s growth potential and its path to uplisting!
🚀🚀 UPLISTING PHASE: EXECUTION MODE (REFRESHED) 🚀🚀
Uplisting preparation is advancing.
Execution is live.
Infrastructure is being built and finalized.
CURRENT DEVELOPMENT STATUS:
• Smart Contracts — Base Sepolia framework progressing
🚀 $TXTM Monumental Week: Shareholder Update + Q3 Filing Unveils Blueprint for the Future
Here’s everything that just changed the entire trajectory of this company 👇
📌 Shareholder Update (Nov 19)
• Debt-free, no dilution, no reverse split.
• $505 million balance sheet noted as debt-free.
• IFRS-audited 2022 & 2023 financials complete, 2024 filings in progress toward PCAOB/Form 10 ambition.
• Strategic support under the TruLeaf LOI recognized as IFRS income/gain (non-cash benefit to balance sheet).
• FX tailwind opportunity via ZAR/USD translation on seed inventory.
• New advisory board addition (Ambassador of Chad) to enhance global strategic depth.
⸻
📌 Q3 Filing Highlights
• Inventory – Genus Cannabis Sativa Seeds valued at $505 M.
• Active Pharmaceutical Ingredients (API) inventory added (historical cost of ~$6.298M, FMV ~$10.71M).
• Assets ~$511 M / Liabilities ~$0.7 M / Equity ~$510.6 M.
• Seed-multiplication program confirmed: 600 M planted, 1 B returned, additional 250 M contributed.
• Pilot-program LOI with ABSA Bank in South Africa: RWA tokenization, stablecoins, custodial walleting, APIs as collateral, carbon-credits inclusion, Ripple/XRP-rails.
• The filing explicitly ties TXTM’s seed inventory + API inventory → RWA → tokenization → new financial pathways.
• Management working for $1/year; CEO bought 209 M common shares personally.
• Operating expenses for the quarter: ~$4,404.
⸻
🎯 Why This Matters More Than Ever
This isn’t just business as usual. TXTM is now operating at the intersection of:
• Next-gen biotech (live-plant extraction, kettle tech)
• Pharmaceutical grade API development (Partnership)
• Tokenized real-world assets (seeds, APIs, carbon credits)
• Institutional finance (bank custody + tokenization + stablecoins)
• Global regulatory alignment (IFRS, RWA accounting, International advisory board)
DrJ has built the foundation, and now the monetization model can start to play out. The model: Biotech output → RWA asset valuation → tokenization/staking → scalable financial ecosystem.
Bottom line:
This is no longer just a seed-to-CBD play. It’s a full-blown biotech + asset-finance + global infrastructure. The market hasn’t yet internalized it.
11/19/25 Q3 👇🏼
https://t.co/FkN0x4V82n
11/19/25 Shareholder Press Release 👇🏼
https://t.co/dG6RMADaEj
#TXTM #Protext #ProtextMobility #TruLeaf
#Biotech #PharmaTech #CBDAPI #CBDInnovation #FECO #Nanotechnology #Bioavailability #RWA #RealWorldAssets #Tokenization #Stablecoin #Blockchain #Fintech #DigitalAssets #IFRS #GAAP #PCAOB #Uplist #InternationalListing
#ABSA #AfricaRising #Ripple #XRP #ACFTA #ShareholderValue #FutureFinance #NewPathways #GlobalHealing
15 MG / capsules
FECO - CBD
RWAs !!!!
Given the Valuations done
Inspected
Insured
And and
Trustify !!
Mint tokens !!
Balance sheet both the token - as cash / cash equivalent
and
the tokens Return !!
Ebita and net profit from staked Coins Guaranteed returns …
As the tokens served as collateral for the financial institution.
Contracts from financial institutions - allows One to forward book revenue …
Exponentiality
((Hope this doesnt upset too Many bashers - Rofl !!!!))
Especially since the same is done With the seed …
Agricultural Commodity
Not different to maize soya sunflower in silo !!!
Has a value - tokenize the RWA …
Nothing New !!!
TXTM !!!
Is not a story. It’s a strategy.
The Human Capital brings decades of global commerce, diplomacy, and biotech to one mission:
📊 PCAOB audit for uplisting
🤝 Acquisition pathways with scale
🌍 Asset tokenization rooted in sovereign alignment (BRICS, AfCFTA)
👥 World-class team from field to lab
This Labor Day, we build what others can’t.
$TXTM | #TXTM #BRICS #LaborDay #GlobalPlatform
⸻
@OptionTrade423 Paytience. I have no time for your FUD. True $TXTM company followers and investors see the vision and the plan coming together. This is a developing company, not a pumpfun crypto.
$TXTM It’s not if, it’s when… and when is getting closer. 1.25 billion seeds, advisory board, 2-year audit, PR firm to assist with press releases and media coverage💥